Keflex and Clotrimazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keflex and Clotrimazole. Common interactions include electrocardiogram qt prolonged among females and pain among males.

The phase IV clinical study analyzes what interactions people who take Keflex and Clotrimazole have. It is created by eHealthMe based on reports of 64 people who take Keflex and Clotrimazole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

64 people who take Keflex and Clotrimazole together, and have interactions are studied.

What is Keflex?

Keflex has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 14,749 Keflex users for its effectiveness, alternative drugs and more.

What is Clotrimazole?

Clotrimazole has active ingredients of clotrimazole. It is often used in thrush. eHealthMe is studying from 11,248 Clotrimazole users for its effectiveness, alternative drugs and more.

Number of Keflex and Clotrimazole reports submitted per year:

Common Keflex and Clotrimazole drug interactions by gender *:

female:

Electrocardiogram qt prolonged
Electrolyte imbalance
Encephalopathy
Failure to thrive
Hypothyroidism
Neutropenia
Pneumonia
Renal failure
Back pain
Fall

male:

Pain
Anxiety
Bone disorder
Bone erosion
Bone pain
Cardiac disorder
Confusional state
Deafness
Decreased appetite
Decubitus ulcer

Common Keflex and Clotrimazole drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

Diabetes insipidus
Electrocardiogram qt prolonged
Electrolyte imbalance
Intestinal pseudo-obstruction

20-29:

Crohn's disease
Injection site haematoma

30-39:

Aphthous ulcer
Cytomegalovirus infection
Decreased appetite
Diarrhoea
Escherichia infection
Fatigue
Musculoskeletal chest pain
Myalgia
Oedema peripheral
Pyrexia

40-49:

Chronic kidney disease
Anaemia
Renal failure
Abdominal pain
Aids related complication
Blood phosphorus increased
Breast cancer
Constipation
Death
Delayed engraftment

50-59:

Hypocalcaemia
Hyponatraemia
Abdominal discomfort
Actinomyces test positive
Anaphylactic reaction
Anhedonia
Arteriosclerosis
Arthralgia
Ataxia
Atelectasis

60+:

Pleural effusion
Anaemia
Weight decreased
Anxiety
Arthralgia
Asthenia
Cardiac failure congestive
General physical health deterioration
Haematuria
Oedema peripheral

Common conditions people have *:

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 23.44%
Pain: 14 people, 21.88%
Prostate Cancer: 11 people, 17.19%
Nausea (feeling of having an urge to vomit): 11 people, 17.19%
Insomnia (sleeplessness): 8 people, 12.50%
Nausea And Vomiting: 7 people, 10.94%
Muscle Spasms (muscle contraction): 7 people, 10.94%
High Blood Pressure: 7 people, 10.94%
Depression: 6 people, 9.38%
Fever: 6 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take Keflex and Clotrimazole?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Keflex (14,749 reports)
Clotrimazole (11,248 reports)